Locoregional Therapies for Hepatocellular Carcinoma
The evolution of locoregional therapies in the last decade has been refined with improved patient selection and a development of a more personalized approach. In doing so, there has been associated improved outcomes and less toxicity. With the rapidly changing landscape of systemic therapy, the role of locoregional therapies alone or in combination for downstaging and curative intent will continue to evolve.
Source: Clinics in Liver Disease - Category: Gastroenterology Authors: Anjana A. Pillai, Meera Ramanathan, Laura Kulik Source Type: research
More News: Cancer & Oncology | Carcinoma | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Toxicology | Urology & Nephrology